Cardiovascular MRI: The Future is Now - Washington Hospital Center

More documents

Recommendations

Info

STICH Trial Bonow RO et al, NEJM 2011;364:1617-25
Limitations of STICH Crossover in 17% medical arm, 9 % in CABG arm Small proportion randomized 2 patients per site randomized per year on average Viability substudy pts. not randomized Viability testing optional – only ½ of pts. from main trial Differences in baseline character<strong>is</strong>tics Limited tests for viability – DSE, SPECT Binary classification of viability Revascularization not guided by presence of viability Small n with nonviability P Chareonthaitawee et al, JACC Img 2012;5:550-8
Page 1 and 2: Assessment of Viability with CMR: W
Page 3 and 4: Viability testing and outcomes Annu
Page 5: STICH Trial Velasquez EJ et al, NEJ
Page 9 and 10: Infarct detection/transmurality Tec
Page 11 and 12: Size of HE Choi et al Circulation 2
Page 13 and 14: Reproducibility 48 pts., 3 centers
Page 15 and 16: SPECT vs. CMR 78 pts. acute MI at d
Page 17 and 18: LGE and prognosis Kwong, RY et al.
Page 19 and 20: Regional function %S 30 25 20 15 10
Page 21 and 22: Time to reperfusion Tarantini G et
Page 23 and 24: AMI - T2-W edema imaging - area at
Page 25 and 26: T2-W - edema/area at risk
Page 27 and 28: Hibernation - Late gadolinium enhan
Page 29 and 30: LGE vs. PET 31 pts., ischemic LV dy
Page 31 and 32: Viability - Late gadolinium enhance
Page 33 and 34: Viability - dobutamine tagged MRI 1
Page 35 and 36: Example images - nonviable segment
Page 37 and 38: Contrast vs. dobutamine All segment
Page 39: Conclusions If viability is of inte

Cardiovascular MRI: The Future is Now - Washington Hospital Center

Create successful ePaper yourself

Delete template?

Save as template?